Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3021
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 1,135 $4,401,261 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $4,401,261 Current and potential, with all options
- Last date to order 9% complete
- IDV ceiling <1% used
- $9,999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) SPE2DR25D3021 is a $9,999,999,999 single-award contract issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for the DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program Generation V, which aims to establish prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract covers an extensive array of medical commodities, such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across multiple therapeutic domains. The IDC has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion for the program. This unrestricted, fully competitive acquisition will be awarded based on the lowest overall price, with the intention to make multiple regional awards to at least three different contractors to ensure supply chain resiliency.
In addition to the DLA IDC, Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, which covers similar medical products and prescription drugs. These comprehensive IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.
Task orders
Show 40 more
Latest 50 of 1,135 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3021?
SPE2DR25D3021 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3021 worth?
Orders under SPE2DR25D3021 have obligated $4,401,261. SPE2DR25D3021's own ceiling is $9,999,999,999.
How many orders have been placed under contract SPE2DR25D3021?
1,135 orders have been placed under SPE2DR25D3021, the latest on July 25, 2026.
Who can order from contract SPE2DR25D3021?
SPE2DR25D3021 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3021 competed?
The extent of competition for SPE2DR25D3021 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV